Key result
Indoxyl sulfate induces angiotensinogen expression in proximal tubular cells through a coordinated mechanism involving CREB, NF-κB, and NADPH oxidase 4.
Why the study?
Does indoxyl sulfate upregulate angiotensinogen expression via CREB, NF-κB, and NOX4 in proximal tubular cells?
Does indoxyl sulfate upregulate angiotensinogen expression via CREB, NF-κB, and NOX4 in proximal tubular cells?
Indoxyl sulfate upregulates angiotensinogen expression in proximal tubular cells through a coordinated pathway involving CREB, NF-κB, and NOX4, providing mechanistic insight into CKD-related renin-angiotensin system activation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for indoxyl sulfate in CKD-related RAS activation; requires in vivo and clinical validation before therapeutic consideration.
In chronic kidney disease (CKD), indoxyl sulfate, a uremic toxin, accumulates in serum, and the expression of angiotensinogen (AGT) is upregulated in renal proximal tubular cells. The present study aimed to determine the relationship between indoxyl sulfate and the upregulation of AGT expression in proximal tubular cells. Indoxyl sulfate induced expression of AGT in rat renal cortex and in cultured human proximal tubular cells (HK-2). In proximal tubular cells, indoxyl sulfate induced phosphorylation of cAMP response element-binding protein (CREB) on Ser-133, and small interfering RNA (siRNA) specific to CREB inhibited indoxyl sulfate-induced AGT expression. Our previous study demonstrated that indoxyl sulfate activated nuclear factor-κB (NF-κB) through reactive oxygen species (ROS) production. NF-κB inhibitors (pyrrolidine dithiocarbamate and isohelenin), NF-κB p65 siRNA, an antioxidant [N-acetylcysteine (NAC)], and a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor [diphenyleneiodonium (DPI)] suppressed indoxyl sulfate-induced AGT expression. Both NAC and DPI suppressed indoxyl sulfate-induced expression of NF-κB p65 and CREB. CREB siRNA suppressed indoxyl sulfate-induced NF-κB p65 expression, whereas both NF-κB inhibitors and NF-κB p65 siRNA prevented indoxyl sulfate-induced CREB expression. Furthermore, we focused on the expression of NADPH oxidase 4 (NOX4), because indoxyl sulfate induced NOX4 expression in vascular smooth muscle cells and vascular endothelial cells. Indoxyl sulfate induced the expression of NOX4 in proximal tubular cells, which was suppressed by NAC, DPI, NF-κB inhibitors, NF-κB p65 siRNA, and CREB siRNA. Taken together, CREB, NF-κB, and NOX4 coordinately upregulate indoxyl sulfate-induced AGT expression in proximal tubular cells.
No takes yet. Share an insight, caveat, or question.
Shimizu et al. (2013) studied Chronic kidney disease. Indoxyl sulfate was evaluated on Angiotensinogen (AGT) expression. Indoxyl sulfate induces angiotensinogen expression in proximal tubular cells through a coordinated mechanism involving CREB, NF-κB, and NADPH oxidase 4.
Synapse has enriched 10 related papers. Consider them for comparative context: